Syndesmophyte growth in ankylosing spondylitis

Current Opinion in Rheumatology

Volumn 27, Issue 4, 2015, Pages 326-332

  Tan, Sovira ^a   Wang, Runsheng ^a   Ward, Michael M ^a  

^a NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

Ankylosing spondylitis; Computed tomography; MRI; Syndesmophytes; Tumor necrosis factor alpha inhibitors

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; VASCULOTROPIN; WNT1 PROTEIN; BIOLOGICAL PRODUCT; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR;

ANKYLOSING SPONDYLITIS; BONE DISEASE; BONE DYSPLASIA; BONE EROSION; BONE MARROW EDEMA; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; INFLAMMATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PATHOGENESIS; POSITRON EMISSION TOMOGRAPHY; PREDICTOR VARIABLE; PRIORITY JOURNAL; REVIEW; SCLEROSIS; SCORING SYSTEM; SEX DIFFERENCE; SYNDESMOPHYTE; ANTAGONISTS AND INHIBITORS; DIAGNOSTIC IMAGING; PATHOLOGY; SPINE; SPONDYLITIS, ANKYLOSING; X-RAY COMPUTED TOMOGRAPHY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL PRODUCTS; DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; SPINE; SPONDYLITIS, ANKYLOSING; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84942566031     PISSN: 10408711     EISSN: 15316963     Source Type: Journal    
DOI: 10.1097/BOR.0000000000000179     Document Type: Review

References (31)

1. Creemers MC, Franssen MJ, Van't Hof MA, et al. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis 2005;64:127-129.
2. Ramiro S, Stolwijk C, Van Tubergen A, et al. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study. Ann Rheum Dis 2015;74:52-59.
3. Braun J, Baraliakos X, Hermann KGA, et al. The effect of two golimumab doses on radiographic progression in ankylosing spondylitis: results through 4 years of the GO-RAISE trial. Ann Rheum Dis 2014;73:1107-1113.
4. Baraliakos X, Heldmann F, Callhoff J, et al. Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and conventional radiography. Ann Rheum Dis 2014;73:1819-1825.
5. Maksymowych WP, Morency N, Conner B, et al. Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification. Ann Rheum Dis 2013;72:23-28.
6. Kang KY, Kwok SK, Ju JH, et al. The predictors of development of new syndesmophytes in female patients with ankylosing spondylitis. Scand J Rheumatol 2015;44:125-128.
7. Tan S, Yao J, Flynn JA, et al. Quantitative measurement of syndesmophyte volume and height in ankylosing spondylitis using CT. Ann Rheum Dis 2014;73:544-550.
8. Tan S, Yao J, Flynn JA, et al. Quantitative syndesmophyte measurement in ankylosing spondylitis using CT: longitudinal validity and sensitivity to change over 2 years. Ann Rheum Dis 2015;74:437-443.
9. Tan S, Yao J, Flynn JA, et al. Dynamics of syndesmophyte growth in AS as measured by quantitative CT: heterogeneity within and among vertebral disc spaces. Rheumatology 2014. [Epub ahead of print] doi: 10.1093/rheumatology/keu423.
10. Poddubnyy D, Haibel H, Listing J, et al. Cigarette smoking has a dosedependent impact on progression of structural damage in the spine in patients with axial spondyloarthritis: results from the German SPondyloarthritis Inception Cohort (GESPIC). Ann Rheum Dis 2013. [Epub ahead of print] doi:10.1136/annrheumdis-2012-203148.
11. Chung HY, Machado P, Van Der Heijde D, et al. Smokers in early axial spondyloarthritis have earlier disease onset, more disease activity, inflammation and damage, and poorer function and health-related quality of life: results from the DESIR cohort. Ann Rheum Dis 2012;71:809-816.
12. Van Tubergen A, Ramiro S, Van Der Heijde D, et al. Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study. Ann Rheum Dis 2012;71:518-523.
13. Ramiro S, Van Der Heijde D, Van Tubergen A, et al. Higher disease activity leads to more structural damage in the spine in ankylosing spondylitis: 12-year longitudinal data from the OASIS cohort. Ann Rheum Dis 2014;73:1455-1461.
14. Ramiro S, Van Tubergen A, Van Der Heijde D, et al. Erosions and sclerosis on radiographs precede the subsequent development of syndesmophytes at the same site: a twelve-year prospective follow up of patients with ankylosing spondylitis. Arthritis Rheumatol 2014;66:2773-2779.
15. Bruijnen STG, Van Der Weijden MAC, Klein JP, et al. Bone formation rather than inflammation reflectsAnkylosing Spondylitis activity on PET-CT: a pilot study. Arthritis Research & Therapy 2012;14:R71. doi: 10.1186/ar3792.
16. Lee SG, Kim IJ, Kim KY, et al. Assessment of bone synthetic activity in inflammatory lesions and syndesmophytes in patients with ankylosing spondylitis: the potential role of 18F-fluoride positron emission tomography-magnetic resonance imaging. Clin Exp Rheumatol 2015;33:90-97.
17. Diarra D, Stolina M, Polzer K, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007;13:156-163.
18. Uderhardt S, Diarra D, Katzenbeisser J, et al. Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints. Ann Rheum Dis 2010;69:592-597.
19. Daoussis D, Liossis SN, Solomou EE, et al. Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum 2010;62:150-158.
20. Heiland GR, Appel H, Poddubnyy D, et al. High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis. Ann Rheum Dis 2012;71:572-574.
21. Appel H, Ruiz-Heiland G, Listing J, et al. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum 2009;60:3257-3262.
22. Klingberg E, Nurkkala M, Carlsten H, Forsblad-D'Elia H. Biomarkers of bone metabolism in ankylosing spondylitis in relation to osteoproliferation and osteoporosis. J Rheumatol 2014;41:1349-1356.
23. Poddubnyy D, Conrad K, Haibel H, et al. Elevated serum level of the vascular endothelial growth factor predicts radiographic spinal progression in patients with axial spondyloarthritis. Ann Rheum Dis 2014;73:2137-2143.
24. Maksymowych WP, Landewe R, Conner-Spady B, et al. Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis Rheum 2007;56:1846-1853.
25. Bay-Jensen AC, Karsdal MA, Vassiliadis E, et al. Circulating citrullinated vimentin fragments reflect disease burden in ankylosing spondylitis and have prognostic capacity for radiographic progression. Arthritis Rheum 2013;65:972-980.
26. Syrbe U, Callhoff J, Conrad K, et al. Serum adipokine levels in patients with ankylosing spondylitis and their relationship to clinical parameters and radiographic spinal progression. Arthritis Rheumatol 2015;67:678-685.
27. Maksymowych WP, Chiowchanwisawakit P, Clare T, et al. Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 2009;60:93-102.
28. Baraliakos X, Haibel H, Listing J, et al. Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis. Ann Rheum Dis 2014;73:710-715.
29. Haroon N, Inman RD, Learch TJ, et al. The impact of tumor necrosis factor alpha inhibitors on radiographic progression in ankylosing spondylitis. Arthritis Rheum 2013;65:2645-2654.
30. Kroon F, Landewe R, Dougados M, Van Der Heijde D. Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis 2012;71:1623-1629.
31. Poddubnyy D, Rudwaleit M, Haibel H, et al. Effect of nonsteroidal antiinflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis 2012;71:1616-1622.